# A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction

> **NCT02277613** · PHASE2 · TERMINATED · sponsor: **Healios K.K.** · enrollment: 34 (actual)

## Conditions studied

- Heart Attack
- NSTEMI

## Interventions

- **BIOLOGICAL:** AMI MultiStem cells
- **OTHER:** Sham

## Key facts

- **NCT ID:** NCT02277613
- **Lead sponsor:** Healios K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12
- **Primary completion:** 2019-06
- **Final completion:** 2020-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02277613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02277613, "A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02277613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*